Moclavin (Amoxicillin, Clavulanic Acid)

Moclavin (amoxicillin/clavulanic acid) is used to treat bacterial infections affecting several organ systems.

• Respiratory tract infections: helps clear pneumonia and bronchitis caused by susceptible bacteria.
• Sinusitis: reduces sinus inflammation and bacterial load, improving drainage.
• Otitis media: eradicates middle‑ear pathogens, relieving pain and hearing loss.
• Urinary tract infections: eliminates common uropathogens, restoring normal urinary function.
• Skin and soft‑tissue infections: combats cellulitis and wound infections caused by susceptible organisms.

• Amoxicillin binds to penicillin‑binding proteins, inhibiting the final step of bacterial cell‑wall peptidoglycan synthesis, which leads to cell lysis. Clavulanic acid, a beta‑lactamase inhibitor, protects amoxicillin from enzymatic degradation by beta‑lactamase‑producing bacteria, extending its antibacterial spectrum.

Adverse reactions may occur with Moclavin and should be monitored.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: feeling of stomach upset.
• Vomiting: expulsion of stomach contents.
• Rash: mild skin erythema or itching.
• Headache: transient cranial discomfort.
• Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with airway compromise.
• Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
• Liver enzyme elevation: signs of hepatic stress.
• Clostridioides difficile infection: severe colitis after disruption of gut flora.
• Severe neutropenia: marked reduction in white blood cells.
• Hemolytic anemia: destruction of red blood cells leading to fatigue and pallor.

Before prescribing Moclavin, clinicians should consider several safety measures.

• Allergy assessment: confirm no known hypersensitivity to penicillins or beta‑lactamase inhibitors.
• Liver function monitoring: check hepatic enzymes in patients with liver disease.
• Renal impairment: adjust dose for reduced kidney clearance.
• History of colitis: avoid in patients with prior Clostridioides difficile infection.
• Elderly patients: start with lower doses and monitor for adverse effects.
• Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Moclavin can affect the activity of several other medicines, requiring attention to potential interactions.

Major Interactions (Avoid)

• Warfarin: increased anticoagulant effect, risk of bleeding.
• Oral contraceptives: reduced efficacy, risk of unintended pregnancy.
• Allopurinol: heightened risk of rash.
• Methotrexate: increased toxicity, especially at high doses.
• Probenecid: elevated amoxicillin plasma levels, possible toxicity.

Moderate Interactions (Monitor Closely)

• Diuretics (e.g., furosemide): may increase risk of electrolyte imbalance.
• Antacids containing aluminum or magnesium: reduce absorption of amoxicillin.
• Iron supplements: chelation may lower antibiotic bioavailability.
• Carbapenems (e.g., imipenem): antagonistic effect, reduced antibacterial activity.
• Certain antivirals (e.g., valacyclovir): may require dose adjustment.